Key positives include rapid revenue growth, a much larger operating scale, and a strong liquidity position despite recent losses. Strategically, ABL has built a distinctive position in life settlements and longevity assets, anchored by proprietary data, AI‑driven underwriting, and a vertically integrated model. The balance sheet now holds substantial assets and equity, demonstrating that the company has been able to attract capital and execute acquisitions. Its technology and asset management ambitions provide multiple avenues for long‑term growth if execution improves.

The main concerns center on financial sustainability. Profitability has reversed from very strong to clearly negative, operating and free cash flow are deeply in the red, and the company has leaned heavily on debt and equity issuance to fund growth. Rising leverage, large goodwill and intangible balances, and negative retained earnings all increase financial and execution risk, especially if acquired businesses underperform or if capital markets become less accommodating. On top of this, ABL faces model, regulatory, and competitive risks in a relatively opaque and specialized asset class.

Overall, ABL appears to be a high-growth, innovation‑driven platform that is still in the process of proving out its long‑term economics. The opportunity lies in converting its scale, data, and technology into durable, cash‑generating franchises across life settlements and broader asset-based finance. The challenge is to stabilize margins, restore positive cash flow, and manage leverage while integrating acquisitions and expanding into new areas. The future trajectory will largely depend on whether management can rebalance the business from “growth at any cost” toward disciplined, profitable expansion without undermining its competitive and technological momentum.